The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Salt as a Promoter of Th17 Cells and Autoimmune Disease

Salt as a Promoter of Th17 Cells and Autoimmune Disease

May 21, 2013 • By Lara C. Pullen, PhD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Th17 cells are interleukin (IL) 17–producing helper cells that are a key component in the induction of multiple autoimmune diseases. Th17 cells are stabilized and given pathogenic effector functions by the presence of IL-23. A new study finds that serum glucocorticoid kinase I (SGK1) plays a critical role in this process. SGK1, an enzyme located primarily in the gut and kidney, regulates sodium absorption and sodium balance.

You Might Also Like
  • Th17 Cells Explained
  • Research Suggests Th17 Cells Have Microbiota-Dependent Role in RA
  • Gut Microbes Activate T Cells Causing Autoimmune Eye Disease
Also By This Author
  • Intensive Program Relieves Symptoms of Juvenile Fibromyalgia

Chuan Wu, PhD of Harvard Medical School in Boston, and colleagues recently reported the results of their microarray data analysis online on in Nature.1 The authors performed transcriptional profiling of developing Th17 cells in order to characterize their signaling network and identify the major nodes that regulate Th17 development. They combined the microarray data with large-scale protein–protein interaction (PPI) network analysis and experimental data from several different knockout mice. They wove the data together to establish IL-23R–SGK1-Foxo1 as a critical axis for stabilizing Th17 cells.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Functionally, the authors found that if they increased salt, they were able to induce SGK1 and increase the number of Th17 cells. This was true both in vitro as well as in vivo.

They and colleagues at Yale also found that mice that were placed on a high salt diet became more susceptible to an autoimmune model of multiple sclerosis (experimental autoimmune encephalomyelitis; EAE). This increase in severity was very much reduced in SGK1-deficient mice. The results suggest that a high salt diet may be a risk factor for inflammation. The data are consistent with recent studies that demonstrated that diet and gut microbiota can have a strong effect on the frequency of effector T cells in the gut.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“I was very surprised … We never went out looking for salt-sensing molecules,” explains Vijay K. Kuchroo, DVM, PhD, also of Harvard Medical School and senior author of the study. He elaborates that the results “build an interesting hypothesis … but careful clinical trials have to be done in humans.”

Dr. Kuchroo points out that the study was one of a series of three papers published back to back in Nature. The first study identified 39 regulatory factors involved in Th17 development and highlighted drug targets that might be useful for controlling Th17 cell differentiation. The second paper (discussed above) described the role of SGK1. The third paper detailed how mice fed a high-salt diet develop more severe EAE with peripherally induced antigen-specific Th17 cells.

Markus Kleinewietfeld, PhD, of Yale School of Medicine in New Haven, Conn., and colleagues conclude in the third paper that the data justify clinical trials of dietary salt restriction in patients with multiple sclerosis and psoriasis, both of which have strong Th17 components.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Pullen is a medical writer based in the Chicago area.

Reference

  1. Wu C, Yosef N, Thalhamer T, et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature. 2013;496:513-517.

Pages: 1 2 | Multi-Page

Filed Under: Research Reviews Tagged With: Autoimmune disease, IL-23, inflammation, Salt, Th17

You Might Also Like:
  • Th17 Cells Explained
  • Research Suggests Th17 Cells Have Microbiota-Dependent Role in RA
  • Gut Microbes Activate T Cells Causing Autoimmune Eye Disease
  • High-Salt Diet May Trigger Gene Silencing & a Lupus Phenotype

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)